2026

CMS released its CY2027 outpatient and ASC proposed rule on July 2. Twelve days later it released the CY2027 physician fee schedule. The comment windows close on different dates — August 31 for the outpatient rule, September 14 for the physician rule — and most of the trade coverage has handled them as two separate stories, one about facilities and one about physicians. Read … [Read more...] about CMS 2027: Who Pays for the Implant When the Surgeon Owns the ASC?

Seventy systems, reimbursement falling around nine percent a year, and a patient population that keeps getting older. Posterior cervical fixation wins the demographic argument in spine and still gets treated as a checkbox. It sits behind lumbar interbody in most portfolio reviews, behind whatever the enabling-technology line item is that quarter, and the commercial teams … [Read more...] about Posterior Cervical: The Segment Everyone Serves and Nobody Owns

The Carlsbad company stretches its fixation brand north — and rents Medtronic's navigation footprint to get there. Spinal Elements has launched Overwatch PCF, a posterior cervical fixation system, and the name matters more than the launch copy suggests. Until now Overwatch has been a thoracolumbar franchise, running from the thoracic spine down through the sacrum and into … [Read more...] about Spinal Elements Takes Overwatch to the Neck

BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec®, a developer of surgical technologies for spine and orthopedic procedures, today announced that it has been named to the 2026 Inc. 5000, the annual list of the fastest-growing private companies in America. The prestigious list recognizes companies that have achieved remarkable growth while driving innovation, creating jobs, and … [Read more...] about SurGenTec® Named to the 2026 Inc. 5000 List of America’s Fastest-Growing Private Companies

GENEVA, Aug. 11, 2026 /PRNewswire/ -- Spineart announces that the BAGUERA® C cervical disc has received FDA approval for 1 and 2 contiguous levels, expanding access in the United States to a motion-preserving solution for patients suffering from cervical disc disease. As one of Spineart's foundational technologies and a cornerstone of its cervical portfolio, … [Read more...] about Spineart Announces FDA Approval of BAGUERA® C Cervical Disc

NEW YORK--(BUSINESS WIRE)--VB Spine LLC ("VB Spine"), the largest privately held spine company, today announced it has completed its acquisition of the exclusive rights to Augmedics' CT-to-fluoroscopy (CT-Fluoro) technology for spine applications and will immediately begin integrating the technology into the xvision Spine System® platform. "We are pleased to complete this … [Read more...] about VB Spine Completes Transaction for CT-Fluoro Technology from Augmedics

MONTEREY, Calif.--(BUSINESS WIRE)--Elevation Spine announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Saber-XA™, an anterior lumbar interbody fusion (ALIF) system that combines expandable cage technology with a zero-profile, FDA-cleared anterior lumbar plate. Saber-XA expandable technology enables true intra-operative customization … [Read more...] about Elevation Spine Receives FDA 510(k) Clearance for Saber-XA™, an Expandable Anterior Lumbar Interbody Fusion (ALIF) System

HumanTech Spine GmbH has introduced cannulated, fenestrated reduction screws for its VENUS posterior stabilization system, the first product extension announced since the company completed its initial certifications under the European Medical Device Regulation. The new implants allow guidewire-assisted screw insertion and provide implant-based reduction, broadening the range … [Read more...] about HumanTech Spine Expands VENUS System With Cannulated, Fenestrated Reduction Screws

Plano, TX, July 14, 2026 --(PR.com)-- Eminent Spine, a leader in advanced 3D implant technology, releases the early clinical and implant results of the world's first FDA 510(k) approved 3D printed titanium pedicle screw. The proprietary 3D printed pedicle screw, designed and manufactured by Eminent Spine received FDA 501(k) clearance on April 28, 2025. The new novel 3D … [Read more...] about Clinical Based Evidence of Eminent Spine’s 3D Printed Titanium Pedicle Screw

AUDUBON, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the second quarter ended June 30, 2026. Second Quarter 2026: “Momentum continued into the second quarter with 6% overall revenue growth, or 9% growth excluding Nevro, … [Read more...] about Globus Medical Reports Second Quarter 2026 Results

Appointment builds on Providence's category leadership in Total Segmental Fusion (TSF) Pleasanton, Calif. — August 6, 2026 — Providence Medical Technology, Inc., an innovator in differentiated spinal fusion technologies designed to improve patient outcomes, today announced that its Board of Directors has appointed Lane Major as President & Chief Executive Officer. Major … [Read more...] about Providence™ Medical Technology Appoints Lane Major as President & Chief Executive Officer

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both net sales and adjusted EBITDA. All pro forma … [Read more...] about Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress

FRUITA, CO — August 4, 2026 — Neuralytix, LLC (www.nerve.health) today announced full commercial availability of its iD3 System, an FDA 510(k)-cleared mechanomyography (MMG) platform that gives spine surgeons real-time, objective feedback on neurophysiologic changes occurring throughout decompression surgery. The launch builds on the system's initial commercial release in … [Read more...] about Neuralytix Announces Full Commercial Availability of iD3 System for Intraoperative Nerve Assessment in Spine Surgery

CARLSBAD, Calif.--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2026, and business highlights. Second Quarter 2026 Financial Results Second Quarter … [Read more...] about ATEC Reports Second Quarter Financial Results

The Los Angeles-based navigation company integrates its RJB angle measurement technology with NuEyes' wearable platforms Spine navigation has a placement problem. The technology works — the accuracy data is not seriously contested — but the monitors that display it sit at the edge of the room, not in the surgeon's line of sight. Attending to them means looking away from the … [Read more...] about Ruthless Spine Moves Into the Surgeon’s Field of View

August 03, 2026 16:09 ET  | Source: SI-BONE, Inc. Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Recent Operational Highlights (any comparisons are to the prior year … [Read more...] about SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance

CARLSBAD, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that the Centers for Medicare & Medicaid Services (CMS) has finalized a favorable reimbursement policy applicable to inpatient aprevo® Lumbar spinal … [Read more...] about Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

H1 2026 results The Board of Directors of Spineway, meeting on July 30, 2026 under the chairmanship of Stéphane Le Roux, approved the financial statements for the six months to June 30, 2026.  Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded second-quarter 2026 revenue of €3.5 million, a sharp increase of … [Read more...] about Spineway : H1 2026 results